These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1386262)

  • 1. A prospective study of skeletal changes during short-term acitretin therapy.
    Hohl D; Pelloni F; Sigg C; Gilardi S; Jung T
    Dermatology; 1992; 185(1):23-6. PubMed ID: 1386262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.
    DiGiovanna JJ; Helfgott RK; Gerber LH; Peck GL
    N Engl J Med; 1986 Nov; 315(19):1177-82. PubMed ID: 3463863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of retinoids in bone.
    Kilcoyne RF
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):212-6. PubMed ID: 2970477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acitretin therapy in keratinization disorders].
    van Dooren-Greebe RJ; van de Kerkhof PC; Steijlen PM; Happle R
    Ned Tijdschr Geneeskd; 1990 Oct; 134(41):1995-2000. PubMed ID: 2146515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
    Halioua B; Saurat JH
    Br J Dermatol; 1990 Jun; 122 Suppl 36():135-50. PubMed ID: 2142437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities.
    Van Dooren-Greebe RJ; Lemmens JA; De Boo T; Hangx NM; Kuijpers AL; Van de Kerkhof PC
    Br J Dermatol; 1996 Jan; 134(1):71-6. PubMed ID: 8745889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term radiographic follow-up after isotretinoin therapy.
    Ellis CN; Pennes DR; Hermann RC; Blauvelt A; Martel W; Voorhees JJ
    J Am Acad Dermatol; 1988 Jun; 18(6):1252-61. PubMed ID: 2968377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and side effects of acitretin on the disorders of keratinization: a one-year study.
    Kullavanijaya P; Kulthanan K
    J Dermatol; 1993 Aug; 20(8):501-6. PubMed ID: 8245313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acitretin in the symptomatic therapy for severe recessive x-linked ichthyosis.
    Bruckner-Tuderman L; Sigg C; Geiger JM; Gilardi S
    Arch Dermatol; 1988 Apr; 124(4):529-32. PubMed ID: 2965549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H; Rinck G; Bitterling T; Orfanos CE
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retinoids: the new status. Maintenance therapy, disorders of resorption in "non-responders", interactions and interferences with drugs, treatment of children and bone toxicity, acitetin and 13-cis-acitretin].
    Orfanos CE
    Hautarzt; 1989 Mar; 40(3):123-9. PubMed ID: 2523875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of skeletal changes associated with long-term administration of 13-cis-retinoic acid.
    Lawson JP; McGuire J
    Skeletal Radiol; 1987; 16(2):91-7. PubMed ID: 3107131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin).
    van Ditzhuijsen TJ; van Haelst UJ; van Dooren-Greebe RJ; van de Kerkhof PC; Yap SH
    J Hepatol; 1990 Sep; 11(2):185-8. PubMed ID: 2147707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP; Finlay AY
    Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful retinoid therapy of Netherton syndrome].
    Hartschuh W; Hausser I; Petzoldt D
    Hautarzt; 1989 Jul; 40(7):430-3. PubMed ID: 2527214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acitretin treatment of severe psoriasis.
    Török L; Kádár L; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():104-6. PubMed ID: 2532840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and skeletal side effects of two years' acitretin treatment.
    Mørk NJ; Kolbenstvedt A; Austad J
    Acta Derm Venereol; 1992 Nov; 72(6):445-8. PubMed ID: 1362840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent etretinate levels in plasma after changing the therapy to acitretin.
    Lambert WE; De Leenheer AP; De Bersaques JP; Kint A
    Arch Dermatol Res; 1990; 282(5):343-4. PubMed ID: 2145814
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis.
    Ruzicka T; Sommerburg C; Braun-Falco O; Köster W; Lengen W; Lensing W; Letzel H; Meigel WN; Paul E; Przybilla B
    Arch Dermatol; 1990 Apr; 126(4):482-6. PubMed ID: 2138875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.